Literature DB >> 35348532

CORR Insights®: What Is the Cumulative Incidence of Revision Surgery and What Are the Complications Associated With Stemmed Cementless Nonextendable Endoprostheses in Patients 18 Years or Younger With Primary Bone Sarcomas About the Knee.

Stein Jasper Janssen1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35348532      PMCID： PMC9191307          DOI： 10.1097/CORR.0000000000002188

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.755


× No keyword cloud information.
  7 in total

1.  Endoprosthetic reconstruction in 250 patients with sarcoma.

Authors:  Georg Gosheger; Carsten Gebert; Helmut Ahrens; Arne Streitbuerger; Winfried Winkelmann; Jendrik Hardes
Journal:  Clin Orthop Relat Res       Date:  2006-09       Impact factor: 4.176

Review 2.  Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies.

Authors:  Ivan R Diamond; Robert C Grant; Brian M Feldman; Paul B Pencharz; Simon C Ling; Aideen M Moore; Paul W Wales
Journal:  J Clin Epidemiol       Date:  2014-04       Impact factor: 6.437

3.  Very long-term outcomes after endoprosthetic replacement for malignant tumours of bone.

Authors:  R J Grimer; B K Aydin; H Wafa; S R Carter; L Jeys; A Abudu; M Parry
Journal:  Bone Joint J       Date:  2016-06       Impact factor: 5.082

4.  What is the Cumulative Incidence of Revision Surgery and What Are the Complications Associated With Stemmed Cementless Nonextendable Endoprostheses in Patients 18 Years or Younger With Primary Bone Sarcomas About the Knee.

Authors:  Ahmed Mohamed El Ghoneimy; Amin Mohamed Shehab; Nesma Farid
Journal:  Clin Orthop Relat Res       Date:  2022-02-16       Impact factor: 4.755

5.  What was the survival of megaprostheses in lower limb reconstructions after tumor resections?

Authors:  Rodolfo Capanna; Guido Scoccianti; Filippo Frenos; Antonio Vilardi; Giovanni Beltrami; Domenico Andrea Campanacci
Journal:  Clin Orthop Relat Res       Date:  2015-03       Impact factor: 4.176

6.  Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial.

Authors:  Michelle Ghert; Patricia Schneider; Gordon Guyatt; Lehana Thabane; Roberto Vélez; Timothy O'Shea; R Lor Randall; Robert Turcotte; David Wilson; Jay S Wunder; André Mathias Baptista; Edward Y Cheng; Yee-Cheen Doung; Peter C Ferguson; Victoria Giglio; James Hayden; Diane Heels-Ansdell; Shah Alam Khan; Venkatesan Sampath Kumar; Paula McKay; Benjamin Miller; Michiel van de Sande; Juan P Zumárraga; Mohit Bhandari
Journal:  JAMA Oncol       Date:  2022-03-01       Impact factor: 33.006

7.  What Are the Long-term Results of MUTARS® Modular Endoprostheses for Reconstruction of Tumor Resection of the Distal Femur and Proximal Tibia?

Authors:  Michaël P A Bus; Michiel A J van de Sande; Marta Fiocco; Gerard R Schaap; Jos A M Bramer; P D Sander Dijkstra
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.